Global Biomarkers Market to touch an aggregate of $78.9 billion by 2024 growing at a CAGR of 12.2% till 2024

Global Biomarkers Market is expected to USD 78.9 billion by 2024, from USD 31.4 billion in 2016 growing at a CAGR of 12.2% during the forecast period of 2017 to 2024
Global Biomarkers Market, By Product Type (Consumables, Services, Softwares), Technology (Efficacy, Safety, Validation), Application (Diagnostics, Drug Discovery, Personalized Medicine, Disease Risk Assessment), Indication (Cancer, Cardiovascular, Immunological), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Global Biomarkers Market is expected to USD 78.9 billion by 2024, from USD 31.4 billion in 2016 growing at a CAGR of 12.2% during the forecast period of 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Brief Sample of the Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-biomarkers-market#utm_source=Abnewswire&utm_campaign=Shubham

Factors that led to growth in the Global Biomarkers Market are increase in research and development financing and in drugs discovery along with the spending more in healthcare activities. The developing use of biomarkers in medical areas (cancer treatment) and new players entrants will definitely lead to the growth of biomarkers market in future. Biomarkers are widely used to distinguish diseases such as, cancer, cardiovascular disorders, neurological disorders, immunological disorders and many others. In the field of oncology, as of late three natural markers have been added to breast cancer disease risk models to distinguish ladies at a higher danger.

Major Market Drivers and Restraints:

  • Increase in R&D financing and healthcare expenditure
  • Developing number of CROs
  • Rising utility of biomarkers for treatment purposes
  • Ease in leading clinical trials in developing countries
  • High capital ventures and cost-to-profit proportions
  • High cost of testing, sample collection, and storage
  • Administrative and reimbursement challenges

The market is segmented on the basis of type, technology, application, indication, and geography.

Read more about the report @ http://databridgemarketresearch.com/reports/global-biomarkers-market/#utm_source=Abnewswire&utm_campaign=Shubham

Based On Type:

  • Consumables
  • Services
  • Softwares

Based on Technology:

  • Efficacy
  • Safety
  • Validation Biomakers

Based On Application:

  • Diagnostics
  • Drug Discovery
  • Personalized Medicine
  • Disease Risk Assessment

Based On Indication:

  • Cancer
  • Cardiovascular Disorders
  • Immunological Disorders

Based on geography the market is segmented into 5 major countries such as North America, South America, Europe, Asia-Pacific, and Middle East & Africa. The major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.

The Global Biomarkers Market Report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.

Major Player Operating in Global Biomarkers Market:

  • QIAGEN
  • PerkinElmer, Inc.
  • Merck & Co.
  • Bio-Rad Laboratories Inc.
  • Enzo Biochem Inc.
  • EKF Diagnostics Holdings Plc
  • Abbott
  • Siemens AG
  • MESO SCALE DIAGOSTICS, LLC
  • Agilent Technologies
  • Singulex, Inc.
  • Cisbio Bioassays
  • Thermo Fisher Scientific Inc.
  • Bruker
  • Biosims Technologies
  • Epigenomics AG
  • Signosis, Inc.
  • GE Healthcare 

Request for TOC: http://databridgemarketresearch.com/toc/?dbmr=global-biomarkers-market#utm_source=Abnewswire&utm_campaign=Shubham

Table Of Content:

1.INTRODUCTION

 

1.1.OVERVIEW OF THE GLOBAL BIOMARKERS MARKET

 

1.2.MARKET SEGMENTATION & COVERAGE

 

1.2.1.CURRENCY AND PRICING

 

1.2.2.LIMITATION

 

1.2.3.STAKEHOLDERS

 

2.RESEARCH METHODOLOGY

 

2.1.KEY TAKEAWAYS

 

2.2.ARRIVING AT THE GLOBAL BIOMARKERS MARKET SIZE

 

2.2.1.MARKET CRACKDOWN APPROACH

 

2.2.2.COMPANY REVENUE AND MARKET SHARE ANALYSIS

 

2.2.3.DATA TRIANGULATION

 

2.2.4.KEY DATA POINTS FROM PRIMARY SOURCES

 

2.2.5.PRODUCT PIPELINE ANALYSIS

 

2.2.6.PORTER’S FIVE FORCES MATRIX

 

2.3.GLOBAL BIOMARKERS MARKET: RESEARCH SNAPSHOT

 

2.4.ASSUMPTIONS

 

3.MARKET LANDSCAPE SUMMARY

 

4.PREMIUM INSIGHTS

 

4.1.OVERVIEW

 

4.2.GLOBAL BIOMARKERS MARKET: KEY PRIMARY INSIGHTS

 

4.3.MARKET OVERVIEW

 

4.3.1.DRIVERS

 

4.3.1.1.INCREASING HEALTHCARE EXPENDITURE

 

4.3.1.2.NON-INVASIVE

 

4.3.1.3.LOW-COST FOR CONDUCTING CLINICAL TRIALS

 

4.3.1.4.GROWING NUMBER OF CROs

 

4.3.2.RESTRAINTS

 

4.3.3.OPPURTUNITIES

 

4.3.4.THREATS

 

4.4.KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

 

5.EXECUTIVE SUMMARY

 

6.BIOMARKERS MARKET, BY PRODUCT TYPE

 

6.1.OVERVIEW

 

6.2.CONSUMABLES,

 

6.3.SERVICES,

 

6.4.SOFTWARE,

 

7.BIOMARKERS MARKET, BY TECHNOLOGY

 

7.1.OVERVIEW

 

7.2.SAFETY BIOMARKERS

 

7.3.EFFICACY BIOMARKERS

 

7.4.VALIDATION BIOMARKERS

 

8.BIOMARKERS MARKET, BY APPLICATION

 

8.1.    OVERVIEW

 

8.2.    DIAGNOSTICS DEVELOPMENT

 

8.3.    DRUG DISCOVERY AND DEVELOPMENT

 

8.4.    PERSONALIZED MEDICINE

 

8.5     DISEASE-RISK ASSESSMENT

 

8.6.    OTHERS

 

9.BIOMARKERS MARKET, BY INDICATION

 

9.1.OVERVIEW

 

9.2.CANCER

 

9.3.CARDIOVASCULAR DISORDERS

 

9.4.NEUROLOGICAL DISORDERS

 

9.5.IMMUNOLOGICAL DISORDERS

 

9.6.OTHER DISEASES

 

10.BIOMARKERS MARKET, BY GEOGRAPHY

 

10.1.COUNTRYWISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

 

10.1.1.NORTH AMERICA

 

10.1.1.1.U.S.

 

10.1.1.2.CANADA

 

10.1.1.3.MEXICO

 

10.1.2.EUROPE

 

10.1.2.1.GERMANY

 

10.1.2.2.FRANCE

 

10.1.2.3.U.K.

 

10.1.2.4.ITALY

 

10.1.2.5.SPAIN

 

10.1.2.6.RUSSIA

 

10.1.2.7.TURKEY

 

10.1.2.8.BELGIUM

 

10.1.2.9.NETHERLANDS

 

10.1.2.10.SWITZERLAND

 

10.1.2.11.REST OF EUROPE

 

10.1.3.ASIA-PACIFIC (APAC)

 

10.1.3.1.JAPAN

 

10.1.3.2.CHINA

 

10.1.3.3.SOUTH KOREA

 

10.1.3.4.INDIA

 

10.1.3.5.AUSTRALIA

 

10.1.3.6.SINGAPORE

 

10.1.3.7.THAILAND

 

10.1.3.8.MALAYSIA

 

10.1.3.9.INDONESIA

 

10.1.3.10.PHILIPPINES

 

10.1.3.11.REST OF APAC

 

10.1.4.LATIN AMERICA

 

10.1.4.1.BRAZIL

 

10.1.4.2.REST OF LATIN AMERICA

 

10.1.5.MIDDLE EAST AND AFRICA

 

10.1.5.1.SOUTH AFRICA

 

10.1.5.2.REST OF MIDDLE EAST AND AFRICA

 

10.2.KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

 

11.BIOMARKERS MARKET: COMPETITIVE LANDSCAPE

 

11.1.GLOBAL BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

 

11.2.U.S. BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

 

11.3.EUROPE BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

 

11.4.APAC BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

 

11.5.SOUTH AMERICA BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

 

11.6.MIDDLE EAST AND AFRICA BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

 

11.7.MERGERS & ACQUISITIONS

 

11.8.NEW PRODUCT DEVELOPMENT & APPROVALS

 

11.9.EXPANSIONS

 

11.10.REGULATORY CHANGES

 

11.11.PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

 

12.BIOMARKERS MARKET, COMPANY PROFILES

 

12.1.QIAGEN N.V

 

12.1.1.COMPANY OVERVIEW

 

12.1.2.SWOT ANALYSIS

 

12.1.3.REVENUE ANALYSIS

 

12.1.4.PRODUCT PORTFOLIO

 

12.1.5.RECENT DEVELOPEMENTS

 

12.1.6.DATA BRIDGE ANALYSIS

 

12.2.PERKINELMER, INC

 

12.2.1.COMPANY OVERVIEW

 

12.2.2.SWOT ANALYSIS

 

12.2.3.REVENUE ANALYSIS

 

12.2.4.PRODUCT PORTFOLIO

 

12.2.5.RECENT DEVELOPEMENTS

 

12.2.6.DATA BRIDGE ANALYSIS

 

12.3.MERCK & CO, INC.

 

12.3.1.COMPANY OVERVIEW

 

12.3.2.SWOT ANALYSIS

 

12.3.3.REVENUE ANALYSIS

 

12.3.4.PRODUCT PORTFOLIO

 

12.3.5.RECENT DEVELOPEMENTS

 

12.3.6.DATA BRIDGE ANALYSIS

 

12.4.BIO-RAD LABORATORIES

 

12.4.1.COMPANY OVERVIEW

 

12.4.2.SWOT ANALYSIS

 

12.4.3.REVENUE ANALYSIS

 

12.4.4.PRODUCT PORTFOLIO

 

12.4.5.RECENT DEVELOPEMENTS

 

12.4.6.DATA BRIDGE ANALYSIS

 

12.5.ENZO BIOCHEM, INC.,

 

12.5.1.COMPANY OVERVIEW

 

12.5.2.SWOT ANALYSIS

 

12.5.3.REVENUE ANALYSIS

 

12.5.4.PRODUCT PORTFOLIO

 

12.5.5.RECENT DEVELOPEMENTS

 

12.5.6.DATA BRIDGE ANALYSIS

 

12.6.EKF DIAGNOSTICS HOLDINGS, PLC

 

12.6.1.COMPANY OVERVIEW

 

12.6.2.SWOT ANALYSIS

 

12.6.3.REVENUE ANALYSIS

 

12.6.4.PRODUCT PORTFOLIO

 

12.6.5.RECENT DEVELOPEMENTS

 

12.6.6.DATA BRIDGE ANALYSIS

 

12.7.MESO SCALE DIAGNOSTICS

 

12.7.1.COMPANY OVERVIEW

 

12.7.2.SWOT ANALYSIS

 

12.7.3.REVENUE ANALYSIS

 

12.7.4.PRODUCT PORTFOLIO

 

12.7.5.RECENT DEVELOPEMENTS

 

12.7.6.DATA BRIDGE ANALYSIS

 

12.8.LLC, SINGULEX, INC.,

 

12.8.1.COMPANY OVERVIEW

 

12.8.2.SWOT ANALYSIS

 

12.8.3.REVENUE ANALYSIS

 

12.8.4.PRODUCT PORTFOLIO

 

12.8.5.RECENT DEVELOPEMENTS

 

12.8.6.DATA BRIDGE ANALYSIS

 

12.9.CISBIO BIOASSAYS

 

12.9.1.COMPANY OVERVIEW

 

12.9.2.SWOT ANALYSIS

 

12.9.3.REVENUE ANALYSIS

 

12.9.4.PRODUCT PORTFOLIO

 

12.9.5.RECENT DEVELOPEMENTS

 

12.9.6.DATA BRIDGE ANALYSIS

 

12.10.BIOSIMS TECHNOLOGIES

 

12.10.1.COMPANY OVERVIEW

 

12.10.2.SWOT ANALYSIS

 

12.10.3.REVENUE ANALYSIS

 

12.10.4.PRODUCT PORTFOLIO

 

12.10.5.RECENT DEVELOPEMENTS

 

12.10.6.DATA BRIDGE ANALYSIS

 

12.11. SIGNOSIS, INC.

 

12.11.1.COMPANY OVERVIEW

 

12.11.2.SWOT ANALYSIS

 

12.11.3.REVENUE ANALYSIS

 

12.11.4.PRODUCT PORTFOLIO

 

12.11.5.RECENT DEVELOPEMENTS

 

12.11.6.DATA BRIDGE ANALYSIS

 

13.APPENDIX

 

14.ABOUT DATA BRIDGE MARKET RESEARCH

Other Report

Global Drug Delivery Devices Market – Trends and Forecast to 2024

Global Drug Delivery Devices Market, By Route of Administration (Oral, Injectable, Topical, Pulmonary, Nasal, Ocular, Implantable, Transmucosal), End-User (Hospitals, Clinics, Home Care Settings), Distribution Channel (Direct Tenders,Hospital Pharmacies), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa) – Trends and Forecast To 2024

Report Access: http://databridgemarketresearch.com/reports/global-drug-delivery-devices-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Ankit Singh

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor: investors@databridgemarketresearch.com

Visit Blog http://databridgemarketresearch.com/blog/ 

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Vishal Dixit
Email: Send Email
Phone: +1-888-387-2818
Address:Office Number 317, Amanora Chambers, Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-biomarkers-market/